Benzoate and phenylacetate

Benzoate and phenylacetate
Trade Name Ucephan
Orphan Indication For adjunctive therapy in the prevention and treatment of hyperammonemia in patients with urea cycle enzymopathy due to carbamylphosphate synthetase, ornithine, transcarbamylase, or argininosuccinate synthetase deficiency
USA Market Approval USA
USA Designation Date 1986-01-21 00:00:00
Sponsor ImmunexImmunex;2525 McGaw Avenue, P.O. Box 19791;Irvine, California, 92623